MD BOLIGUTVIKLING AS

Signals

2 flags

• ▼ Negativ egenkapital 2024 Bokført egenkapital er negativ (−2,3 mill kr).
• ▼ Driftsunderskudd 2024 Siste driftsresultat er negativt (−2,1 mill kr).

MD BOLIGUTVIKLING AS is registered as a limited company in Bodø, Nordland with organisation number 828691082. The business is classified under construction of residential and non-residential buildings (NACE 41.000). The company was incorporated in 2022. Registered share capital is NOK 30,000, divided into 300 shares. The company's stated purpose is: “Entreprenør virksomhet, oppsett av nybygg, kjøp og salg av fast eiendom.”. The most recent filed accounts, for the 2024 financial year, show NOK 4.9m in revenue and NOK −2.1m in operating profit.

Key figures · 2024

Revenue

NOK 4.9m

▲ +47 %

Operating profit

NOK −2.1m

▼ −172 %

Equity

NOK −2.3m

▼ −373 %

Financial health · 2024

Liquidity

2.65

Very good

Current assets ÷ current liabilities

Profitability

-12.7%

Not satisfactory

Return on total assets

Solidity

-17.5%

Weak

Equity as a share of total capital

Solidity capped at Weak because equity is below NOK 100,000.

Who owns MD BOLIGUTVIKLING AS?

Daniel Eriksen Private shareholder

50.0%

MAMAMA AS Org. no. 921173636

50.0%

MD BOLIGUTVIKLING AS

NOK 4.9m rev. · NOK −2.1m profit

MD BOLIGUTVIKLING AS has 2 registered shareholders:

• Daniel Eriksen 50.0%
• MAMAMA AS 50.0%

All shareholders and roles →

Frequently asked questions about MD BOLIGUTVIKLING AS

Who owns MD BOLIGUTVIKLING AS?

Daniel Eriksen is the largest registered owner, with 50.0%.

What is the revenue of MD BOLIGUTVIKLING AS?

MD BOLIGUTVIKLING AS had revenue of NOK 4.9m in 2024.

Where is MD BOLIGUTVIKLING AS based?

MD BOLIGUTVIKLING AS has its business address in Bodø.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 03.10.2026.